The objective of the Online Adherence Module is to provide pharma, biotech, and device marketers with the necessary data and insights to develop their online adherence strategy to increase sales in the face of shrinking pipelines and expiring patents. It gives an in-depth look at the role the Internet plays in how consumers adhere to treatment today, the outlook for consumer demand for online adherence services in the mid-term, and best practices for manufacturers.
According to the analysis, emerging technology, consumer adoption of new media, and an increasing culture of self-service, among other factors, has put the Internet in a prime position to significantly affect patient adherence, treatment outcomes, and ultimately the manufacturer's bottom line. But along with the opportunities come numerous challenges, especially among certain therapeutic segments, requiring manufacturers implement best practices from the get go.
"Successful adherence programs can greatly benefit manufacturers, as relatively small changes in patient behavior have the potential to substantially increase revenue," said Monique Levy, author of the analysis and Senior Director of Research at Manhattan Research. "Though manufacturers have been somewhat reluctant to put all of their weight behind these types of initiatives in the past due to complexity and cost, digital channels are offering new and effective ways to facilitate patient adherence."
Analysis Outline
Title: Online Adherence Programs: Evaluating Manufacturers' Opportunity to Impact Patient Adherence
Introduction
I. Role of the Internet on Treatment Adherence
Figure 1-1: Adoption of Dedicated Adherence Online Resources
Figure 1-2: Occasions When Consumers Perform Online Health Research
Figure 1-3: Shifts in the Digital Health Media Landscape
Figure 1-4: Adoption of Dedicated Adherence Resources Across Select Therapeutic Segments
Figure 1-5: Occasions in Which Consumers in Different Therapeutic Categories go Online for Health Information
II. Consumer Demand for Online Adherence Resources in the Mid-term
Figure 2-1: Interest in Prescription Refill Reminders
Figure 2-2: Interest in Prescription Refill Reminders Among Online Consumers Who Take Prescription Drugs Across Select Conditions
Figure 2-3: Demand for Health Services on Mobile Devices
Figure 2-4: ePharma Consumer Using or Very Interested in Accessing Information about Prescription Drugs on General Health Sites
Figure 2-5: Drivers and Inhibitors of Online Adherence
Close-up 2-1: Johnson & Johnsonâs CareConnect iPhone App
III. Best Practices for Manufacturers
Key Learnings and Action Items
For an excerpt from the module and more information about its contents, please visit: http://www.manhattanresearch.com/products/Research_Modules/Consumer/online-patient-adherence.aspx.
Access to the "Online Adherence Programs" research module is immediately available to subscribers of Manhattan Research's Cybercitizen Health™ market research and strategic advisory service. For more information about becoming a subscriber to this service and gaining access to the in-depth consumer market data and analysis, visit http://www.manhattanresearch.com/cch.
About Cybercitizen Health™ v8.0
Cybercitizen Health™ v8.0 was fielded in Q3 2008 among 8,714 U.S. adults (ages 18+). This consumer market research and strategic advisory service focuses on how consumers use new media and technology for health and its impact on treatment and product decisions. For topics and available therapeutic segmentations (100+), please visit http://www.manhattanresearch.com/cch.
About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.